MISTY WITTEN: Open Payments
NPI 1427449305 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 17 payments from 12 companies in 2025. Trend: 2023 $230 · 2024 $695 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $146 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| CSL Behring | 2 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Pharmacosmos Therapeutics Inc. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Chiesi USA, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $23 |
Products named: FASENRA, Hizentra, NUCALA, BENLYSTA, VPRIV, EVKEEZA, MONOFERRIC, INJECTAFER.
Industry payments across TX — which companies pay providers there.
